We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index.
- Authors
Joseph, Adrien; Chen, Hui; Anagnostopoulos, Gerasimos; Montégut, Léa; Lafarge, Antoine; Motiño, Omar; Castedo, Maria; Maiuri, Maria Chiara; Clément, Karine; Terrisse, Safae; Martin, Anne Laure; Vaz-Luis, Ines; Andre, Fabrice; Grundler, Franziska; de Toledo, Françoise Wilhelmi; Madeo, Frank; Zitvogel, Laurence; Goldwasser, François; Blanchet, Benoit; Fumeron, Frédéric
- Abstract
In mice, the plasma concentrations of the appetite-stimulatory and autophagy-inhibitory factor acyl-coenzyme A binding protein (ACBP, also called diazepam-binding inhibitor, DBI) acutely increase in response to starvation, but also do so upon chronic overnutrition leading to obesity. Here, we show that knockout of Acbp/Dbi in adipose tissue is sufficient to prevent high-fat diet-induced weight gain in mice. We investigated ACBP/DBI plasma concentrations in several patient cohorts to discover a similar dual pattern of regulation. In relatively healthy subjects, ACBP/DBI concentrations independently correlated with body mass index (BMI) and age. The association between ACBP/DBI and BMI was lost in subjects that underwent major weight gain in the subsequent 3–9 years, as well as in advanced cancer patients. Voluntary fasting, undernutrition in the context of advanced cancer, as well as chemotherapy were associated with an increase in circulating ACBP/DBI levels. Altogether, these results support the conclusion that ACBP/DBI may play an important role in body mass homeostasis as well as in its failure.
- Publication
Cell Death & Disease, 2021, Vol 12, Issue 6, p1
- ISSN
2041-4889
- Publication type
Article
- DOI
10.1038/s41419-021-03864-9